rfhg_14742.1

Basic information about the TSS

---

TSS ID: rfhg_14742.1 Species: human Chr: chr1		Start: 160214187 End: 160214236 Strand: +
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: L37385:-118 GeneID: 8682 HGNC/MGI_ID: HGNC:8822 UniProt_ID: Q14801 Nearer transcript ids and distances: LF320791:-174 MA556368:-174 LF320792:-250 MA556369:-250 BC010469:254 DQ579760:341 LF320793:-349 MA556370:-349 KJ901899:380 view more...

Gene_name: proliferation and apoptosis adaptor protein 15 Gene_symbol: PEA15 Gene_synonyms: HMAT1 HUMMAT1H MAT1 MAT1H PEA-15 PED PED-PEA15 PED/PEA15 Gene_source: HGNC:8822

TATA-Box annotation

---

Distance to TSS:	-5342
Nearest PromoterID:	NR_123725
Entrez ID:	729867
Nearest Unigene:	Hs.674191
Nearest Refseq:	NR_123725
Nearest Ensembl:	ENSG00000227741
Gene Name:	proliferation and apoptosis adaptor protein 15
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.580000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PEA15 p2@PEA15 p3@PEA15 p4@PEA15 p5@PEA15
Sample		p1@PEA15	p2@PEA15	p3@PEA15	p4@PEA15	p5@PEA15
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.47	19.48	2.53	0.39	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.98	20.84	2.63	1.01	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.94	14.27	3.47	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.61	21.41	3.53	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.97	22.72	3.15	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.04	25.78	3.10	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.71	30.50	5.45	1.53	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.72	30.76	2.66	0.48	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.82	35.90	3.42	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	55.06	31.88	5.22	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	46.89	33.55	3.23	0.81	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.69	41.47	2.44	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	101.71	24.98	9.51	2.10	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	89.31	22.85	8.72	1.95	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	95.94	28.98	10.98	2.20	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	79.97	25.15	11.82	1.26	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	75.35	19.44	11.14	0.87	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	62.43	13.50	15.61	1.27	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	54.91	17.59	10.66	2.13	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	86.80	17.45	12.94	3.31	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	91.02	20.98	10.29	1.74	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	94.25	23.13	11.57	3.11	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	88.41	20.55	9.05	2.20	3.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	86.63	17.96	10.92	1.94	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	85.14	24.77	13.42	2.84	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	76.60	16.14	10.76	2.53	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	73.63	18.68	14.29	2.75	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	123.30	33.95	8.72	3.06	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	92.55	21.81	16.15	2.58	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	104.78	27.14	12.31	3.80	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	96.93	24.70	18.84	2.30	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	95.54	25.99	13.29	1.95	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	109.52	23.64	24.48	2.32	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	83.46	23.26	17.81	0.99	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	116.87	29.54	19.26	3.18	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	124.56	26.44	9.77	2.68	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	122.01	31.07	21.26	3.27	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	119.48	28.01	15.31	2.62	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	123.98	31.60	15.13	2.43	5.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	115.47	30.49	16.32	2.88	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	113.63	29.17	17.17	2.82	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	104.67	30.30	15.81	3.37	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	123.37	27.42	17.29	4.01	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	123.43	32.52	14.51	2.27	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	147.17	33.93	12.05	2.61	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	122.60	34.43	25.82	2.09	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	124.75	37.19	13.43	4.56	4.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	120.41	34.28	11.33	2.98	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	134.77	39.02	19.15	2.63	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	130.42	37.00	16.38	4.04	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	118.87	48.57	29.72	2.05	9.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	155.88	40.69	30.02	2.89	7.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	69.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	138.04	29.81	18.10	2.84	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	137.19	29.82	16.90	3.98	10.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	68.79	22.65	57.05	0.84	12.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	105.63	28.93	43.63	1.84	8.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	122.84	32.41	17.50	3.24	7.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	102.13	29.87	15.09	2.89	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	130.45	35.83	36.78	2.20	11.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	151.59	34.55	19.04	2.12	5.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	122.25	22.99	24.11	3.36	7.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	170.37	27.07	42.20	2.39	11.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	133.87	28.20	36.69	2.38	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	125.42	23.72	19.82	2.27	5.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	101.88	20.59	22.01	3.19	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	48.49	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	0.00	47.38	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	115.05	19.50	20.96	4.39	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	152.23	28.76	27.27	0.99	5.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	129.01	28.15	10.79	3.28	6.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	102.34	15.23	19.54	1.99	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	105.49	15.47	17.01	2.47	8.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	118.32	17.43	16.51	1.83	3.67
Adipocyte - breast, donor1	11376-118A8	234.57	78.24	15.68	4.12	6.18
Adipocyte - breast, donor2	11327-117E4	191.07	45.40	16.84	6.74	14.92
Adipocyte - omental, donor1	11473-119C6	221.76	66.54	10.18	4.33	4.96
Adipocyte - omental, donor2	11474-119C7	271.34	72.51	14.95	9.72	5.98
Adipocyte - omental, donor3	11475-119C8	209.66	31.82	5.69	5.69	5.69
Adipocyte - perirenal, donor1	11476-119C9	239.25	52.32	12.12	2.55	7.02
Adipocyte - subcutaneous, donor1	11259-116F8	58.27	11.00	2.20	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	107.49	27.55	5.87	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	100.27	19.64	1.91	3.48	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	153.92	30.70	2.15	7.24	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	63.57	21.11	1.80	1.29	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	141.90	36.80	1.39	3.62	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	89.35	24.69	2.35	4.11	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	73.76	12.06	0.88	4.75	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	72.30	15.17	3.23	1.29	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	67.71	26.13	4.27	6.40	4.27
Adipocyte differentiation, day08, donor4	13029-139E5	39.51	13.35	1.11	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	52.82	10.40	0.42	1.25	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	53.25	10.05	2.26	1.26	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	67.74	14.40	2.62	0.65	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	34.41	6.70	0.30	3.65	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	134.81	47.74	1.99	4.42	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	149.89	41.95	5.02	2.15	2.87
Alveolar Epithelial Cells, donor3	11671-122G6	76.67	15.57	2.40	1.20	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	75.56	19.61	2.88	2.70	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	75.31	16.73	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	97.38	29.79	1.44	1.64	0.82
Anulus Pulposus Cell, donor1	11248-116E6	24.37	10.76	1.14	0.92	0.11
Anulus Pulposus Cell, donor2	11463-119B5	38.94	14.69	1.47	1.47	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	94.35	39.09	14.38	3.59	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	109.40	40.38	8.68	4.34	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	96.31	36.38	10.70	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	94.76	36.17	14.35	5.38	5.68
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	130.26	43.00	26.56	2.53	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	79.21	28.38	7.92	2.64	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	102.66	34.44	6.50	1.62	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	114.56	41.75	7.77	3.40	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	73.64	23.76	17.82	5.34	5.34
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	107.72	38.04	12.81	4.90	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	111.03	48.62	9.43	3.63	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	90.27	31.34	16.30	1.25	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	121.08	33.44	4.28	2.97	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	105.09	43.67	13.65	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	82.03	26.39	5.13	2.41	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	115.19	33.22	10.18	4.29	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	133.01	33.44	8.12	4.53	2.65
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	100.50	38.22	7.75	1.87	2.94
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	99.50	38.04	7.80	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	138.99	33.17	6.63	6.47	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	79.25	25.22	15.61	4.80	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	99.12	49.56	17.70	0.00	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	145.11	32.25	6.35	5.66	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	46.14	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	102.91	39.32	11.16	1.46	4.85
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	137.74	35.29	8.35	3.79	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	86.01	23.02	15.75	1.21	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	108.88	33.06	11.40	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	126.55	32.07	5.56	4.92	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	95.75	30.97	7.23	2.84	3.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	112.61	40.82	9.85	2.82	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	126.05	30.55	13.51	5.47	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	89.18	27.82	4.28	2.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	86.57	32.17	8.77	2.34	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	125.55	34.02	7.83	4.22	3.61
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	106.92	20.20	19.01	2.38	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	130.70	41.70	17.80	3.05	5.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	125.82	32.09	25.47	5.09	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	102.93	26.05	5.08	5.72	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	111.77	44.45	12.95	1.73	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	137.38	33.66	7.62	4.02	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	81.19	25.23	6.96	3.77	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	111.48	48.18	10.39	6.61	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	134.60	27.80	6.95	5.76	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	94.97	16.21	13.90	2.32	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	84.50	40.14	19.01	2.11	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	124.14	31.73	8.15	4.29	2.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	80.62	24.07	4.81	1.20	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	102.06	52.49	10.21	4.37	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	129.65	33.79	5.98	4.14	3.91
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	102.01	20.40	45.91	2.55	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	101.95	30.76	7.63	1.02	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	151.94	35.71	7.02	4.75	2.89
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	89.05	32.13	6.12	2.45	3.98
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	101.82	45.41	10.99	1.91	5.26
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	131.05	33.93	7.54	3.77	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	88.50	22.89	15.26	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	95.82	35.45	6.65	2.77	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	129.75	30.98	7.41	4.24	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	103.22	21.44	4.72	1.82	3.63
Astrocyte - cerebellum, donor1	11500-119F6	267.00	134.36	4.67	8.35	1.60
Astrocyte - cerebellum, donor2	11580-120F5	227.81	92.60	7.36	7.19	4.62
Astrocyte - cerebellum, donor3	11661-122F5	185.42	76.98	4.40	3.78	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	360.44	130.02	11.50	9.76	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	209.66	95.45	14.72	8.41	7.77
Astrocyte - cerebral cortex, donor3	11392-118C6	238.21	86.81	5.07	8.50	5.22
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	66.63	20.07	2.06	2.06	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	56.63	20.30	1.50	3.26	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	51.55	16.16	1.71	2.16	1.14
Basophils, donor1	12241-129G9	26.94	5.75	0.26	2.62	0.00
Basophils, donor2	12242-129H1	24.17	1.80	0.36	2.16	0.72
Basophils, donor3	12243-129H2	73.94	6.47	0.59	4.12	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	45.49	11.43	1.72	0.65	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	52.58	14.63	2.74	0.46	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	67.79	21.97	0.63	1.26	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	126.23	42.21	1.04	2.29	2.91
Bronchial Epithelial Cell, donor6	11461-119B3	58.72	13.13	0.92	2.53	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	28.07	8.64	1.26	0.72	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.87	9.69	1.34	0.72	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	41.22	24.45	3.49	2.10	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.67	4.80	0.32	2.56	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	64.81	6.20	1.13	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	46.21	7.24	1.30	2.60	1.30
CD14+ Monocytes, donor3	11381-118B4	51.15	6.37	0.44	1.98	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.95	1.42	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.19	3.79	0.76	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.94	2.30	0.99	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	59.41	6.79	2.46	4.34	3.61
CD14+ monocytes - mock treated, donor2	11873-125C1	107.12	11.47	3.32	2.41	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	113.00	13.50	2.37	4.97	3.55
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	86.21	9.37	3.01	3.18	5.02
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	162.57	17.11	4.42	3.04	4.14
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	188.92	17.85	3.22	5.95	4.46
CD14+ monocytes - treated with BCG, donor1	11860-125A6	73.03	6.85	3.72	0.78	3.92
CD14+ monocytes - treated with BCG, donor2	11870-125B7	109.86	10.68	3.03	2.14	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	107.07	7.62	3.48	3.05	3.26
CD14+ monocytes - treated with Candida, donor1	11868-125B5	72.11	6.56	1.40	1.40	2.81
CD14+ monocytes - treated with Candida, donor2	11878-125C6	133.06	10.03	1.58	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	93.19	8.87	2.22	4.44	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	81.96	8.48	4.31	3.57	4.91
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	168.82	20.95	4.99	2.99	4.99
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	136.37	14.99	5.62	5.83	3.96
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	142.30	11.44	4.58	4.12	5.49
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	129.16	14.25	2.26	2.71	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	151.89	16.15	3.49	2.62	5.24
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	48.42	4.57	2.42	3.50	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	101.01	9.94	2.44	3.14	4.01
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	105.63	18.52	2.52	2.95	3.79
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	140.17	12.68	5.14	2.94	5.51
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	273.71	24.31	1.76	4.93	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	316.32	18.43	4.83	4.83	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	77.77	8.72	3.66	1.92	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	109.64	12.64	4.09	2.23	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	115.32	11.64	3.23	3.23	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	91.32	8.60	3.69	1.64	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	124.71	9.50	2.55	2.78	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	129.45	11.37	3.71	3.71	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	37.27	8.06	2.18	2.62	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	55.67	8.78	1.85	1.85	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	49.61	8.01	1.52	2.82	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	37.53	4.20	2.34	2.02	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	35.45	5.76	1.40	2.62	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	60.42	9.59	0.00	3.57	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	21.18	1.28	0.00	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	15.37	2.42	1.10	0.66	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	21.69	3.37	0.21	1.47	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	30.51	5.42	0.68	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	3.11	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.99	4.26	0.00	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.09	5.90	0.00	3.22	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.89	6.32	0.00	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	3.14	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	27.68	3.95	1.32	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	37.81	7.40	2.47	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	34.10	8.71	2.18	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	40.39	8.08	1.51	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.04	1.62	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.59	0.80	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	4.02	2.01	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	20.23	3.93	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.52	3.01	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5.64	4.28	0.68	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	8.93	1.43	0.00	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	9.19	1.22	1.22	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	12.20	1.52	0.30	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	9.44	2.04	0.26	0.51	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	10.33	3.14	0.22	1.35	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	9.77	2.59	1.15	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	5.22	1.42	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	1.40	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.96	3.32	0.29	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.73	3.73	0.68	1.19	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.15	4.51	1.13	0.97	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	5.38	1.79	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	7.69	2.10	0.35	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	2.20	0.88	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.32	3.79	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	9.14	1.04	0.62	1.25	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.35	0.33	0.33	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5.17	1.90	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.68	0.54	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3.59	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.09	2.23	0.00	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.35	1.95	0.43	2.38	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.09	3.78	0.42	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.56	2.02	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	8.23	3.03	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	11.33	1.31	0.00	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.36	2.97	0.00	0.99	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	9.23	0.92	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.22	5.54	0.28	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.88	2.45	0.25	1.23	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	3.08	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	15.76	2.86	0.00	2.51	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	4.15	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	11.79	1.96	0.00	1.64	0.00
CD8+ T Cells, donor2	11307-117C2	12.01	3.38	1.13	0.38	0.75
CD8+ T Cells, donor3	11383-118B6	8.84	2.52	0.50	1.77	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.20	15.83	1.84	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.74	9.83	1.44	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.67	7.93	2.46	1.37	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.91	7.21	2.10	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.16	18.24	0.72	0.72	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.24	15.69	1.82	0.45	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.38	11.95	1.30	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.06	9.21	0.53	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.46	11.26	1.17	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.68	8.75	0.91	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.07	5.52	2.03	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.92	11.72	1.33	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.39	14.45	0.88	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.07	11.84	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	15.66	0.75	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.49	22.69	1.44	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.55	20.14	2.88	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.27	16.50	2.59	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.77	14.26	0.32	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.30	19.38	0.92	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.91	15.39	0.32	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.77	9.94	1.15	1.15	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	8.28	0.39	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	5.29	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.92	15.26	4.82	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	18.19	4.20	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	59.10	23.04	2.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	124.29	25.59	1.83	7.31	5.48
Cardiac Myocyte, donor2	11605-120I3	26.68	10.38	1.98	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	100.50	27.57	2.00	3.26	0.21
Chondrocyte - de diff, donor1	11261-116G1	160.16	44.72	11.09	1.04	1.04
Chondrocyte - de diff, donor2	11338-117F6	158.14	34.83	5.33	3.55	2.13
Chondrocyte - de diff, donor3	11410-118E6	132.89	30.72	7.85	5.80	1.25
Chondrocyte - re diff, donor2	11339-117F7	144.14	45.66	0.90	4.48	0.90
Chondrocyte - re diff, donor3	11411-118E7	82.09	12.94	3.24	3.24	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	90.66	46.59	4.59	3.90	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	66.91	30.35	4.92	3.21	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	56.46	27.35	2.65	2.65	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	168.55	61.90	3.39	6.60	1.28
Corneal Epithelial Cells, donor1	11526-119I5	52.48	14.93	1.10	1.54	0.66
Corneal Epithelial Cells, donor2	11606-120I4	28.44	19.34	0.00	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	53.94	14.57	1.53	1.53	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	142.48	36.32	4.95	2.15	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	158.97	35.64	3.47	3.78	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	193.24	62.11	3.45	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	165.66	27.54	6.70	4.86	3.46
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.81	12.98	0.68	2.73	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	69.20	14.36	0.00	3.26	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	67.27	13.55	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	144.59	30.35	1.50	6.84	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	123.22	28.75	0.59	5.87	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	141.68	38.18	1.41	3.11	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	147.05	25.95	0.79	2.75	1.97
Endothelial Cells - Artery, donor1	11264-116G4	145.44	29.09	4.94	5.53	2.33
Endothelial Cells - Artery, donor2	11341-117F9	124.23	29.17	5.65	5.65	5.41
Endothelial Cells - Artery, donor3	11413-118E9	157.60	36.29	2.63	5.96	4.03
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.93	11.97	1.77	3.99	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	94.32	21.91	3.35	2.43	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	94.72	18.89	3.38	4.51	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	84.39	24.07	4.75	1.78	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	49.98	21.35	2.60	2.60	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	44.52	8.79	1.56	2.27	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	173.25	52.42	5.20	4.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	150.95	36.16	4.72	7.86	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	77.16	26.09	3.23	3.35	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	59.10	20.42	1.09	4.13	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	105.52	35.78	1.59	5.25	0.73
Endothelial Cells - Vein, donor1	11267-116G7	106.93	29.58	3.41	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	87.31	27.94	0.70	4.89	1.40
Endothelial Cells - Vein, donor3	11416-118F3	121.52	26.06	2.04	5.34	1.57
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	11.55	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	39.58	11.73	0.49	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	89.45	16.64	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	256.16	52.55	10.26	6.98	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	134.89	36.46	34.05	2.63	6.79
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	94.47	31.31	30.66	2.28	3.79
Fibroblast - Aortic Adventitial, donor1	11245-116E3	139.11	50.94	7.64	4.73	2.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	150.66	38.62	2.87	6.82	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	191.74	55.90	10.55	5.48	7.80
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	47.69	18.18	1.32	1.05	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	130.89	30.89	5.65	6.31	2.99
Fibroblast - Cardiac, donor1	11268-116G8	158.32	36.29	7.71	4.08	4.54
Fibroblast - Cardiac, donor2	11345-117G4	91.71	22.74	0.76	6.06	0.76
Fibroblast - Cardiac, donor3	11417-118F4	130.59	36.43	5.05	2.52	1.26
Fibroblast - Cardiac, donor4	11452-119A3	90.93	24.55	0.30	5.46	1.21
Fibroblast - Cardiac, donor5	11456-119A7	92.64	20.05	2.66	4.57	2.54
Fibroblast - Cardiac, donor6	11460-119B2	101.42	23.35	3.34	4.85	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	127.96	35.37	2.28	2.41	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	53.93	17.69	2.59	2.16	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	42.48	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	146.46	61.81	3.46	5.77	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	37.65	8.99	1.02	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	70.90	25.36	1.88	3.29	1.88
Fibroblast - Dermal, donor2	11346-117G5	112.26	50.94	0.94	3.77	0.94
Fibroblast - Dermal, donor3	11418-118F5	67.94	22.12	3.99	2.42	1.21
Fibroblast - Dermal, donor4	11450-119A1	61.38	21.03	2.60	2.37	2.03
Fibroblast - Dermal, donor5	11454-119A5	80.07	23.73	3.84	1.40	1.40
Fibroblast - Dermal, donor6	11458-119A9	77.96	28.75	2.11	1.14	1.30
Fibroblast - Gingival, donor1	11237-116D4	82.46	20.82	1.04	2.92	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	230.56	79.39	7.34	8.12	5.76
Fibroblast - Gingival, donor2	11318-117D4	65.76	28.73	4.09	5.01	1.71
Fibroblast - Gingival, donor3	11394-118C8	82.76	18.85	1.16	2.51	1.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	232.71	63.37	4.16	8.31	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	186.42	51.80	7.93	4.93	7.22
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	186.92	70.15	4.83	6.86	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	149.70	62.34	7.57	5.14	4.73
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	199.38	85.75	0.71	5.29	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	134.98	57.33	4.53	3.36	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	123.26	57.40	4.50	4.23	2.73
Fibroblast - Gingival, donor8 (control)	11926-125H9	169.26	67.68	3.51	6.14	3.40
Fibroblast - Gingival, donor9 (control)	11927-125I1	180.34	36.83	5.28	5.58	4.70
Fibroblast - Lung, donor1	11270-116H1	48.94	6.80	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	13.43	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	51.49	17.73	2.11	2.53	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	229.91	79.97	1.67	3.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	195.81	58.74	4.20	5.59	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	102.99	33.59	1.40	1.40	1.68
Fibroblast - Mammary, donor1	11540-120B1	197.30	74.70	4.06	8.12	0.41
Fibroblast - Mammary, donor2	11620-122A9	139.80	63.91	3.99	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	256.12	47.65	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	72.16	29.48	1.55	2.91	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	87.37	27.76	3.79	4.55	3.19
Fibroblast - Periodontal Ligament, donor3	11395-118C9	221.23	62.42	0.92	10.40	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	211.80	77.09	2.67	4.96	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	218.69	54.27	13.77	10.53	9.45
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	180.46	39.78	2.55	6.38	2.78
Fibroblast - Pulmonary Artery, donor1	11250-116E8	109.98	33.27	5.64	3.43	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	175.96	66.85	2.44	8.33	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	84.86	28.73	2.67	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	50.61	15.81	0.40	3.56	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	97.44	39.09	6.55	1.39	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	149.38	25.75	5.68	3.37	2.13
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	169.30	32.72	9.07	4.34	1.97
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	70.40	25.57	3.01	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	211.26	50.74	6.69	2.91	4.10
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	118.69	35.94	6.58	2.53	1.52
Fibroblast - skin normal, donor1	11553-120C5	222.82	56.44	8.20	8.20	2.63
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	70.18	32.48	2.41	4.41	0.40
Fibroblast - skin normal, donor2	11561-120D4	232.87	73.84	9.54	5.63	5.73
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	120.89	48.36	4.23	5.74	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	216.23	38.85	6.46	4.31	2.65
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	163.94	36.75	6.50	2.91	4.27
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	91.96	35.47	6.57	0.33	3.61
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	282.92	89.48	12.14	2.34	4.15
Fibroblast - skin walker warburg, donor1	11554-120C6	135.28	50.94	6.41	3.37	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	111.50	29.01	35.44	3.14	6.59
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	44.32	132.96	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	68.85	11.33	0.00	6.10	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	151.34	43.86	4.85	3.99	1.91
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	159.27	40.60	2.60	5.73	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	153.31	56.72	2.56	2.56	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.79	29.86	2.30	1.53	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.69	15.95	2.55	0.00	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	54.49	16.26	4.56	1.43	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	42.47	24.82	2.48	1.10	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	55.03	26.03	1.60	1.14	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	45.37	19.61	1.39	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.07	24.05	3.97	2.11	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.77	26.42	1.63	3.26	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.82	13.71	3.10	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.04	18.09	0.99	0.99	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	66.74	30.79	2.22	1.23	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	30.62	15.31	1.34	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	105.19	43.24	3.47	2.11	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	82.09	45.82	3.05	1.11	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	60.18	34.76	4.07	1.22	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	81.92	29.89	3.42	2.28	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	79.35	31.39	2.74	1.37	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	66.01	31.91	2.84	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	89.83	23.05	3.84	2.66	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	84.25	37.67	3.97	1.59	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.70	19.44	1.12	2.68	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	83.88	21.57	4.64	1.81	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	101.95	32.23	5.26	1.19	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.67	24.03	2.93	1.06	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	108.74	27.68	1.87	1.66	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.56	27.32	1.20	2.05	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	87.31	26.00	3.43	1.33	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.57	19.14	1.25	1.50	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	59.42	21.03	1.43	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	77.98	21.04	3.92	4.75	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	81.51	23.06	3.80	1.15	1.96
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.03	13.84	1.50	2.17	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	72.52	15.21	4.85	2.65	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	90.89	22.75	2.71	2.34	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	77.48	22.69	2.92	2.76	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	89.80	21.17	3.85	1.92	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	91.06	27.19	3.13	1.71	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.15	16.61	1.11	1.90	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	88.49	23.11	2.43	1.82	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	93.35	31.36	2.82	1.78	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	51.81	9.88	1.54	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	106.33	31.14	4.21	1.68	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	71.20	26.48	1.48	1.48	2.41
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.85	13.10	2.41	2.67	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	62.27	19.28	3.83	3.37	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	81.22	27.72	3.76	2.07	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.52	7.59	2.17	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	60.10	14.93	3.32	2.58	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	67.33	17.76	5.70	2.41	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	110.08	12.89	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	81.65	18.34	3.83	4.22	1.85
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	78.08	19.57	2.82	3.83	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	162.41	25.67	1.52	4.57	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.80	18.71	1.19	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	45.45	21.42	1.54	1.23	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.57	16.16	1.02	0.61	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.98	15.96	2.82	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	23.73	10.45	1.13	2.26	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	12.45	6.46	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	22.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	44.87	19.34	2.71	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	24.07	22.46	9.63	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	24.34	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	34.83	15.30	2.93	1.95	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	31.71	20.59	4.94	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	13.33	13.33	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.52	12.30	3.36	1.40	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.97	10.79	2.29	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.04	5.87	4.19	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.13	12.40	1.91	0.64	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.85	11.21	2.38	3.06	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	18.79	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	15.46	3.44	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	30.49	10.66	3.26	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	35.58	10.16	5.08	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.88	9.53	3.73	1.66	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.61	10.82	2.76	1.61	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	15.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	34.21	11.53	3.08	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	35.20	9.45	3.26	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.77	12.71	3.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.76	13.10	2.31	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	71.21	16.77	4.11	1.37	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	7.45	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	38.69	9.91	4.72	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.62	7.24	3.02	1.81	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	10.68	2.03	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.86	11.57	2.79	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	42.92	6.41	2.96	0.49	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	15.35	3.54	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	7.58	3.50	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.15	10.97	5.27	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	6.78	3.39	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	43.57	14.33	7.16	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	36.39	9.70	7.76	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	123.26	38.80	1.14	3.42	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	99.38	42.41	10.40	2.49	3.74
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	150.68	41.60	1.12	5.62	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	74.53	24.74	5.39	6.34	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	71.43	28.82	5.43	4.18	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	24.25	10.56	2.20	0.81	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.29	8.95	1.69	0.34	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	23.21	9.56	1.82	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	25.80	11.15	3.06	1.20	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	26.86	8.81	1.72	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.02	10.55	1.51	1.08	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.28	8.47	1.25	1.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	20.24	10.29	1.20	0.69	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.46	10.57	2.88	0.64	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	93.46	27.98	5.60	1.12	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	154.94	58.86	4.33	2.60	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	84.60	50.23	21.15	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	104.76	53.26	2.12	3.17	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	111.88	62.48	2.18	2.18	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	42.31	18.88	1.92	2.45	1.22
Hepatocyte, donor1	11523-119I2	9.68	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	9.70	2.15	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	29.45	8.59	2.45	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.06	5.94	1.05	0.87	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	72.72	29.64	1.78	4.25	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	19.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	12.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	9.26	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.12	6.93	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	4.64	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	9.04	1.29	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	12.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	16.30	6.52	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.53	5.04	0.42	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.90	4.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	6.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	7.55	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	6.35	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	10.76	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	7.62	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.94	2.55	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	6.43	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.67	9.26	0.93	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	16.69	5.56	0.00	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	8.72	0.00	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	2.13	2.13	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	8.31	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	12.89	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	9.08	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	6.34	5.29	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	88.37	36.15	2.61	1.39	1.39
Keratinocyte - epidermal, donor2	11349-117G8	38.07	15.81	0.59	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	63.23	16.19	1.89	2.65	0.85
Keratinocyte - oral, donor1	11251-116E9	45.18	14.53	0.79	2.84	0.57
Keratocytes, donor1	11527-119I6	314.26	66.02	4.81	4.13	1.72
Keratocytes, donor2	11607-120I5	57.42	30.47	1.17	3.52	2.34
Keratocytes, donor3	11688-122I5	62.64	8.10	0.79	2.57	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	142.86	10.99	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	67.96	23.73	6.47	3.24	2.16
Lens Epithelial Cells, donor2	11609-120I7	190.41	46.02	3.81	8.07	0.58
Lens Epithelial Cells, donor3	11690-122I7	100.20	38.35	1.61	4.84	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	88.58	25.14	3.79	4.86	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	51.91	20.93	2.79	1.95	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	58.09	20.15	4.88	4.41	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	52.70	18.82	4.30	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	68.39	21.43	1.58	6.30	3.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	52.18	14.12	4.20	3.34	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	51.30	24.62	1.64	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	51.58	16.69	3.29	3.03	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	53.49	18.02	4.36	4.08	1.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	45.49	20.17	3.56	2.37	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	54.48	19.39	2.13	2.71	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	54.80	15.55	3.89	3.70	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	57.49	25.09	3.83	3.14	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	57.01	23.85	2.86	4.05	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	60.30	20.19	5.08	3.57	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	61.59	19.40	4.62	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	51.13	13.09	2.18	2.18	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	60.75	23.79	3.11	4.39	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	58.25	23.37	4.61	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	61.50	17.57	4.39	1.17	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	56.76	18.42	5.97	1.24	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	63.53	17.94	0.97	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	58.71	21.81	2.69	0.81	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	56.62	19.22	4.54	3.03	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	40.44	18.66	4.15	2.59	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	55.70	16.54	4.82	3.14	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	62.10	19.25	4.36	2.56	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	52.97	19.26	3.44	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	55.69	12.98	3.01	3.95	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	56.51	20.89	5.41	3.29	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	61.54	18.41	1.94	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	55.24	21.17	1.32	2.98	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	59.72	19.95	3.35	3.10	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	49.98	25.17	4.44	1.48	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	51.64	17.79	3.71	5.19	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.97	20.07	2.47	4.12	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	55.64	21.55	3.22	3.86	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	60.87	15.83	2.13	3.04	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	55.15	15.82	3.22	4.20	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	62.22	20.27	3.91	2.84	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	52.36	26.66	4.85	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	54.77	19.30	3.89	3.11	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	66.97	20.41	5.37	2.51	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	57.49	21.23	1.63	3.27	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	46.38	17.19	4.47	4.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	93.93	25.37	4.58	4.46	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	63.01	15.62	3.84	3.84	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	61.76	17.90	4.77	5.07	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	24.55	4.60	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	4.45	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.66	5.92	1.27	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	7.03	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	2.80	2.80	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	4.12	3.61	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	3.57	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.74	4.52	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.25	6.11	0.87	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	4.50	0.90	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.32	7.18	1.35	1.22	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	5.65	2.57	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	22.58	6.00	0.71	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.99	5.33	3.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.21	7.13	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	27.48	6.14	1.33	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.48	6.05	2.46	0.38	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	4.91	1.84	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	3.26	2.45	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	26.24	8.95	2.71	1.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.26	4.48	4.20	0.84	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	18.55	5.15	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.16	9.00	3.19	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.43	9.86	2.69	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	25.45	7.19	3.32	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	7.42	3.89	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.75	5.90	2.95	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	2.30	1.15	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.65	6.91	1.54	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.72	2.83	3.96	2.26	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	4.10	0.82	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.46	2.26	5.87	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	5.75	0.72	0.00	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	4.48	0.75	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	19.69	7.06	3.34	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.66	5.17	0.86	0.43	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	3.43	2.57	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.32	6.33	5.00	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	4.83	2.41	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	3.55	1.42	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	5.16	4.47	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	4.29	2.15	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.24	8.08	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.45	7.04	4.44	1.85	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	3.49	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	2.12	1.06	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	4.00	2.80	2.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.99	3.63	0.00	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	5.37	1.53	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.26	5.43	2.96	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	5.65	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	24.14	2.51	0.50	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	3.60	1.35	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	5.16	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	31.17	5.34	3.56	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	6.65	3.52	1.17	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	12.53	6.60	1.32	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.68	4.67	1.56	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	23.19	4.81	3.50	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	8.39	1.68	0.56	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	28.27	8.39	2.65	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	7.33	1.54	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	8.61	3.04	1.01	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.55	7.21	2.40	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	9.14	1.99	1.19	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	7.90	2.43	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	5.53	2.08	0.69	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.46	7.22	3.04	0.38	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	9.30	3.10	1.55	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.21	8.47	2.42	0.00	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.20	7.92	2.22	1.27	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	8.00	0.53	1.60	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	14.37	4.60	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	6.17	2.06	1.03	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	7.78	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.21	7.38	4.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.88	7.49	2.50	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	7.83	2.35	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	26.72	12.94	1.25	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.16	6.50	1.39	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	9.37	1.34	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.20	10.16	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.59	7.68	1.62	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	2.75	3.67	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	8.00	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.35	10.83	0.57	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.77	9.20	7.67	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	8.21	3.28	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.62	8.02	4.01	0.89	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.05	11.44	0.52	1.56	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.83	9.95	3.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	29.10	4.16	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	61.31	14.59	1.37	1.60	0.91
Macrophage - monocyte derived, donor2	11313-117C8	166.62	49.91	2.75	5.14	1.84
Macrophage - monocyte derived, donor3	11389-118C3	194.39	51.91	5.24	5.90	3.41
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	80.72	27.61	2.12	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	186.50	53.87	5.55	4.12	2.22
Mallassez-derived cells, donor3	11930-125I4	107.58	29.33	2.78	3.20	0.83
Mammary Epithelial Cell, donor1	11273-116H4	71.54	25.81	2.69	1.59	0.10
Mammary Epithelial Cell, donor2	11350-117G9	50.67	28.95	2.90	2.32	0.29
Mammary Epithelial Cell, donor3	11422-118F9	59.36	24.44	0.25	2.00	0.25
Mast cell - stimulated, donor1	11487-119E2	193.89	45.42	0.00	6.78	0.00
Mast cell, donor1	11563-120D6	51.48	8.54	1.19	3.57	0.11
Mast cell, donor2	11565-120D8	26.45	4.75	0.00	0.89	0.00
Mast cell, donor3	11566-120D9	22.29	5.18	0.23	0.90	1.35
Mast cell, donor4	11567-120E1	18.79	2.66	0.18	1.77	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	58.11	12.20	2.44	2.44	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	68.29	25.10	5.84	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	33.38	5.74	1.15	1.95	0.46
Mast cell, expanded, donor8	11941-126A6	29.29	7.70	1.84	4.35	0.33
Melanocyte - dark, donor1	11502-119F8	54.72	13.83	0.99	3.88	0.20
Melanocyte - dark, donor2	11582-120F7	28.03	7.96	1.38	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	91.06	28.54	1.74	6.66	0.58
Melanocyte - light, donor1	11274-116H5	82.51	23.74	2.35	3.06	0.24
Melanocyte - light, donor2	11351-117H1	48.46	10.24	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	66.78	16.48	1.73	1.73	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	134.74	48.63	5.52	3.85	3.75
Melanocyte, donor2 (MC+2)	12739-135I3	48.14	19.09	1.88	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	65.89	10.98	1.87	1.61	0.54
Meningeal Cells, donor1	11493-119E8	199.74	88.21	1.12	5.83	1.24
Meningeal Cells, donor2	11573-120E7	128.96	35.65	0.88	3.52	3.08
Meningeal Cells, donor3	11654-122E7	85.98	49.15	3.67	4.40	2.28
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.50	14.54	2.00	2.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	119.15	40.45	2.62	3.42	1.71
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	36.80	14.46	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	79.80	30.09	1.31	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.81	35.88	5.02	5.02	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	135.96	41.29	5.51	5.51	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	143.25	67.35	6.03	4.02	7.04
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	63.73	34.06	2.86	1.32	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	67.94	47.49	4.38	3.65	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	78.77	36.83	2.25	1.43	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	55.68	18.01	1.80	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	72.86	21.56	1.12	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.16	8.95	1.71	1.32	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.99	4.45	2.08	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	7.01	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	62.12	22.41	2.56	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	99.24	44.31	2.48	3.54	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	59.42	9.07	0.94	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	10.16	0.00	4.35	0.00
Mesothelial Cells, donor1	11247-116E5	378.67	107.93	7.42	10.08	3.45
Mesothelial Cells, donor2	12156-128G5	337.31	104.60	2.50	7.51	8.01
Mesothelial Cells, donor3	11402-118D7	346.87	84.19	7.88	9.11	7.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	152.59	60.76	0.00	5.40	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	178.30	60.34	1.23	3.94	3.69
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	127.80	53.59	1.47	4.12	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	141.74	93.34	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	107.24	33.78	2.17	2.17	3.72
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	105.17	36.30	3.32	2.70	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	152.86	67.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	143.65	37.79	5.26	4.50	3.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	132.20	48.41	2.33	4.65	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	214.13	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	152.82	38.20	3.05	4.27	3.66
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	96.61	37.22	3.17	2.38	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	265.10	179.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	110.62	27.43	8.85	0.88	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	110.56	42.93	4.94	1.52	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	168.44	102.64	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	114.39	34.59	5.09	3.18	2.55
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	124.31	44.20	1.84	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	135.02	36.36	4.77	2.98	3.58
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	206.23	73.77	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	305.54	305.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	123.19	30.86	4.77	2.51	5.77
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	117.17	35.41	1.90	3.33	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	172.50	74.64	0.55	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	128.94	40.75	4.37	3.22	3.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	115.90	46.70	1.26	2.31	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	138.20	39.14	1.02	4.08	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	107.05	34.33	3.00	2.57	4.51
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	134.26	44.24	2.00	3.11	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	268.28	82.55	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	124.62	33.51	3.07	3.50	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	146.00	60.33	1.01	2.53	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	228.67	104.39	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	141.60	50.55	2.45	3.26	4.08
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	119.69	45.58	2.06	4.12	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	138.47	115.57	2.18	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	128.79	33.16	3.36	1.92	3.36
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	97.26	45.63	6.00	2.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	266.02	60.33	0.00	6.86	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	121.64	46.05	6.51	1.00	7.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	262.97	38.73	0.00	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	136.19	37.22	5.26	2.19	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	211.90	93.81	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	235.66	61.48	0.00	3.20	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	134.12	48.10	4.21	3.72	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	190.68	89.77	0.00	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	276.23	106.07	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	141.54	44.44	6.15	3.76	4.10
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	155.79	46.39	0.88	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	223.71	74.93	0.00	2.13	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	147.29	44.61	4.77	2.52	3.65
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	156.69	69.83	0.83	1.25	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	206.29	62.35	1.17	5.24	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	135.15	48.27	4.83	3.02	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	136.07	55.10	1.67	2.09	4.59
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	101.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	122.83	59.11	1.85	1.85	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	170.17	60.33	1.14	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	168.03	64.53	1.52	4.56	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	105.73	36.28	4.15	4.15	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	166.01	57.05	1.29	3.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	173.41	59.71	0.00	5.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	125.97	59.78	2.14	3.74	2.67
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	234.97	89.80	2.99	3.59	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	157.07	46.76	1.84	2.68	1.55
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	98.74	38.54	3.82	2.55	2.87
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	158.55	53.07	2.65	1.77	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	156.99	46.64	1.52	5.31	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	119.61	48.58	3.13	3.69	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	190.01	55.80	4.92	3.44	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	241.12	73.64	1.30	9.12	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	150.84	57.04	5.29	3.53	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	211.63	70.64	3.46	2.88	4.32
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	211.43	53.99	2.06	6.18	4.12
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	184.63	55.98	2.08	2.68	4.76
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	11.30	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	65.94	16.04	7.13	3.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	118.94	17.74	4.93	5.26	4.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	128.34	36.82	6.31	4.21	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	49.42	11.86	2.97	0.99	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	114.55	39.12	3.73	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	75.48	18.40	3.00	3.76	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	111.60	37.82	4.26	4.53	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	78.61	14.82	0.90	1.13	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	55.25	13.26	4.42	1.47	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	113.96	22.72	3.66	3.30	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	126.00	28.00	29.56	10.89	12.44
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	82.84	25.12	2.14	2.67	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	3.86	15.46	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	132.30	19.19	10.10	6.06	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	153.90	51.02	5.90	7.17	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	49.03	13.62	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	41.33	7.63	1.27	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	27.53	9.72	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	129.90	19.64	6.04	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	17.13	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	172.91	42.41	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	28.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	12.55	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	218.24	76.26	11.42	7.32	2.80
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	121.77	37.11	8.36	2.61	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	90.11	33.37	7.34	3.34	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	204.51	38.40	5.01	6.68	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	116.94	44.87	8.94	2.47	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	338.32	86.18	1.60	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	65.27	20.40	8.16	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	9.19	7.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	33.06	8.37	6.70	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	105.53	27.66	7.44	3.02	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	40.26	16.75	4.32	1.62	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	115.84	38.47	1.68	2.10	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	40.70	27.80	4.96	2.48	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.10	14.07	5.68	1.89	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	50.55	15.64	8.61	1.13	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	56.01	13.88	3.59	1.96	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	118.47	29.71	6.01	4.37	2.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	57.29	24.93	6.37	1.06	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	60.63	19.81	6.60	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	69.57	18.71	13.46	0.66	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	66.68	12.52	7.48	2.93	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	194.55	49.74	5.12	3.88	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	72.43	16.17	8.44	0.00	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	80.91	16.55	9.65	4.14	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	64.91	15.75	6.75	2.57	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	115.88	24.49	28.28	3.10	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	111.25	53.10	10.11	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	189.14	47.45	3.12	4.01	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	90.18	17.78	11.85	2.54	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	96.13	21.36	10.68	2.61	2.14
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	84.13	18.46	7.30	1.29	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	36.11	45.14	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	158.61	30.99	9.33	2.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	262.40	55.01	3.16	4.51	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	80.55	21.43	17.06	1.59	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	66.86	18.57	9.29	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	150.59	19.68	9.84	4.16	2.27
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	195.86	36.50	15.64	4.24	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	186.95	29.20	3.92	5.23	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	357.76	67.84	3.62	4.98	3.17
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	109.36	23.81	19.40	0.88	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	54.52	15.29	8.64	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	139.88	28.77	8.43	2.48	2.48
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	200.60	39.43	11.87	1.91	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	91.94	17.84	3.93	3.33	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	242.24	61.22	6.63	3.76	2.21
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	87.42	23.72	12.88	2.03	5.42
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	20.44	25.55	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	106.69	26.22	10.36	4.88	4.27
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	276.02	41.23	8.18	7.55	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	141.34	16.95	7.57	6.05	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	83.07	20.57	17.41	3.16	5.54
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	198.39	43.08	30.61	6.80	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	10.12	5.06	5.06
Myoblast, donor1	11241-116D8	192.93	76.40	12.05	6.58	3.48
Myoblast, donor2	11322-117D8	105.87	37.59	6.52	4.03	3.64
Myoblast, donor3	11398-118D3	199.44	81.73	6.05	7.90	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.93	6.42	0.88	2.48	0.29
Natural Killer Cells, donor1	11230-116C6	14.76	1.85	0.00	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	13.57	2.11	0.60	1.81	0.30
Natural Killer Cells, donor3	11387-118C1	20.61	3.31	0.37	1.10	0.18
Neural stem cells, donor1	11275-116H6	450.77	287.09	9.07	12.34	8.35
Neural stem cells, donor2	11352-117H2	529.55	258.04	3.85	23.11	9.63
Neurons, donor1	11494-119E9	274.23	106.96	15.93	9.10	5.69
Neurons, donor2	11574-120E8	173.49	71.11	7.49	5.50	0.88
Neurons, donor3	11655-122E8	249.94	69.88	30.42	6.58	2.47
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	42.03	11.04	1.19	2.26	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	24.75	7.81	1.95	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	46.53	14.04	2.21	1.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	107.78	20.37	9.22	2.62	1.79
Olfactory epithelial cells, donor2	11934-125I8	156.04	42.84	42.70	6.66	9.12
Olfactory epithelial cells, donor3	11935-125I9	156.41	31.21	11.35	4.54	2.61
Olfactory epithelial cells, donor4	11936-126A1	226.94	38.37	8.57	5.36	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	149.25	28.89	1.20	5.42	0.00
Osteoblast - differentiated, donor1	11276-116H7	132.72	29.56	1.06	4.04	1.28
Osteoblast - differentiated, donor2	11353-117H3	69.73	22.86	0.00	4.57	5.72
Osteoblast - differentiated, donor3	11425-118G3	50.28	15.52	0.62	4.97	1.24
Osteoblast, donor1	11277-116H8	89.90	46.51	1.76	3.91	0.39
Osteoblast, donor2	11354-117H4	93.41	42.14	5.62	3.51	1.40
Osteoblast, donor3	11426-118G4	151.96	47.81	2.49	5.69	1.24
Pancreatic stromal cells, donor1	11249-116E7	151.79	46.25	6.23	5.05	2.02
Pericytes, donor1	11491-119E6	163.01	50.40	2.34	1.00	0.78
Pericytes, donor2	11571-120E5	172.49	51.61	2.94	2.26	2.72
Pericytes, donor3	11652-122E5	124.51	37.84	5.90	4.48	2.03
Perineurial Cells, donor1	11499-119F5	102.17	28.03	2.26	7.12	0.34
Perineurial Cells, donor2	11579-120F4	34.87	12.15	0.55	2.94	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.29	5.74	0.64	1.27	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.18	4.16	2.20	2.20	2.45
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.58	2.72	0.26	1.68	0.26
Placental Epithelial Cells, donor1	11278-116H9	135.61	28.70	2.39	3.11	0.96
Placental Epithelial Cells, donor2	11355-117H5	94.26	27.72	7.76	2.22	4.44
Placental Epithelial Cells, donor3	11427-118G5	94.43	23.95	3.34	3.53	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	222.78	80.38	60.76	2.53	14.87
Preadipocyte - breast, donor1	11467-119B9	188.90	63.59	11.26	2.25	5.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	199.32	54.56	4.18	7.70	1.44
Preadipocyte - breast, donor2	11328-117E5	260.72	75.88	17.11	8.33	13.51
Preadipocyte - omental, donor1	11468-119C1	236.13	72.78	11.51	3.41	5.97
Preadipocyte - omental, donor2	11329-117E6	292.00	66.34	11.78	11.35	4.36
Preadipocyte - omental, donor3	11403-118D8	328.76	80.22	17.05	11.75	5.73
Preadipocyte - perirenal, donor1	11469-119C2	193.90	45.28	8.86	0.98	4.92
Preadipocyte - subcutaneous, donor1	11279-116I1	123.15	59.89	0.92	2.76	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	113.15	67.47	10.09	4.96	5.31
Preadipocyte - subcutaneous, donor3	11428-118G6	114.43	53.64	4.43	3.58	2.72
Preadipocyte - visceral, donor1	11280-116I2	86.44	51.42	2.89	1.96	0.47
Preadipocyte - visceral, donor2	11357-117H7	79.15	37.73	9.20	3.22	4.60
Preadipocyte - visceral, donor3	11429-118G7	99.79	49.32	5.54	2.09	2.93
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.21	4.37	0.60	1.06	0.91
Prostate Epithelial Cells, donor2	11331-117E8	105.08	32.77	6.91	4.06	5.28
Prostate Epithelial Cells, donor3	11404-118D9	41.46	6.12	1.71	1.22	0.67
Prostate Stromal Cells, donor1	11254-116F3	111.28	45.33	5.24	3.53	1.59
Prostate Stromal Cells, donor2	11332-117E9	145.05	53.97	10.40	3.23	5.38
Prostate Stromal Cells, donor3	11405-118E1	152.87	46.30	9.07	4.48	4.69
Renal Cortical Epithelial Cells, donor1	11516-119H4	90.15	25.18	2.55	2.55	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	82.62	28.42	3.26	2.08	0.97
Renal Epithelial Cells, donor1	11517-119H5	57.32	34.49	2.54	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	73.98	32.72	0.71	4.27	1.42
Renal Epithelial Cells, donor3	11678-122H4	62.99	22.55	2.75	3.39	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	108.94	29.96	4.77	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	126.14	34.50	4.99	3.91	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	93.69	36.41	5.77	3.77	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	69.21	27.28	1.33	1.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	63.83	33.01	2.20	3.08	1.10
Renal Mesangial Cells, donor2	11598-120H5	58.94	31.35	1.25	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	66.86	33.84	1.94	1.94	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	82.14	29.53	1.88	0.81	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	64.52	26.99	1.27	3.80	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	80.03	35.68	2.70	2.31	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	50.82	26.45	2.33	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	92.38	41.22	4.55	2.84	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	68.95	32.93	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	50.68	25.09	2.01	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	105.17	13.76	2.27	3.47	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	61.64	19.65	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	24.22	4.95	2.20	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.20	17.98	0.58	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	90.11	30.30	2.21	0.91	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	73.19	22.54	2.28	1.49	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.45	22.87	1.34	1.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	92.16	31.88	4.09	1.98	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	75.87	28.20	3.61	0.93	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	83.67	24.04	2.31	2.54	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	78.72	23.00	2.05	1.64	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	73.82	24.51	4.24	0.91	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	59.85	21.86	1.61	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	72.88	21.66	3.16	1.29	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	68.47	23.50	2.25	2.15	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	61.73	25.00	3.98	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	66.53	28.87	2.49	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	78.16	26.92	1.40	2.24	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	60.13	20.67	1.69	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	99.13	31.05	2.52	2.79	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	83.03	25.89	2.82	2.24	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	69.89	24.63	3.63	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	91.09	28.09	2.24	1.60	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	60.83	24.11	7.01	2.24	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	71.61	23.58	2.39	1.71	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	82.05	26.07	1.46	1.46	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	75.66	26.73	3.07	1.84	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	75.22	23.91	2.42	1.21	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.47	26.65	5.66	0.00	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	76.19	26.39	2.78	1.79	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	69.22	23.38	3.51	1.64	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	81.91	26.75	4.77	2.28	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	75.87	21.24	6.64	1.55	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	72.48	22.98	2.51	2.92	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	93.27	34.72	2.42	2.02	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	95.71	28.95	1.53	2.38	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	75.19	29.11	2.51	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	80.47	29.06	3.44	1.72	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	81.89	27.43	1.23	2.88	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	63.53	23.64	2.96	1.31	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	73.29	21.99	2.73	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	77.38	26.63	1.92	3.26	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	73.83	19.72	2.40	2.40	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	62.63	17.56	1.24	0.97	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	52.62	13.10	0.95	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.76	20.56	0.60	3.63	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	54.06	13.18	1.79	1.41	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.85	17.12	2.79	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	58.93	18.44	1.81	2.12	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	56.54	13.58	2.94	1.10	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	55.75	16.74	0.87	1.75	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.01	13.39	2.43	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.51	14.77	2.71	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	60.39	14.48	2.94	2.26	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.89	17.07	1.80	1.80	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	62.23	17.83	2.36	2.13	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	70.86	16.65	1.07	2.56	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	73.92	11.42	1.20	3.00	3.61
Schwann Cells, donor1	11498-119F4	102.31	42.32	2.44	3.95	2.44
Schwann Cells, donor2	11578-120F3	54.44	17.01	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	63.75	33.96	5.48	4.16	1.53
Sebocyte, donor1	11220-116B5	213.63	66.28	1.64	7.67	1.64
Sebocyte, donor2	11301-117B5	88.23	22.06	4.60	3.68	7.35
Sebocyte, donor3	11378-118B1	143.45	35.86	2.68	4.33	3.09
Sertoli Cells, donor1	11255-116F4	270.03	54.67	6.63	13.25	3.31
Sertoli Cells, donor2	11333-117F1	197.71	48.01	19.77	16.95	28.24
Skeletal Muscle Cells, donor1	11281-116I3	74.08	22.61	2.55	1.85	0.79
Skeletal Muscle Cells, donor2	11358-117H8	125.05	39.76	5.06	3.61	3.61
Skeletal Muscle Cells, donor3	11430-118G8	81.10	39.29	1.67	0.84	3.34
Skeletal Muscle Cells, donor4	11451-119A2	57.97	22.15	2.20	1.89	1.10
Skeletal Muscle Cells, donor5	11455-119A6	51.13	19.62	1.93	1.19	0.59
Skeletal Muscle Cells, donor6	11459-119B1	76.34	28.16	2.77	2.00	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.12	11.97	2.02	0.88	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.81	15.70	1.85	3.28	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	74.41	33.53	2.38	2.38	1.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	127.22	48.11	3.62	2.19	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	125.93	64.41	0.72	4.34	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	75.95	36.60	2.89	2.89	2.48
Skin - palm, donor1	10286-104F7	134.31	48.35	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	63.14	22.34	7.35	1.15	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	20.45	18.81	8.18	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	50.76	17.53	6.62	0.26	1.95
Small Airway Epithelial Cells, donor1	11256-116F5	75.34	18.49	4.45	1.67	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	111.96	24.19	3.38	3.66	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	67.66	26.43	1.27	3.59	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	81.25	12.67	2.02	2.17	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	158.00	59.87	47.83	1.54	4.63
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	84.26	34.02	2.22	1.56	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	149.90	57.61	0.59	7.64	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	124.86	24.97	1.99	4.64	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	188.62	53.55	2.76	2.76	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	129.79	43.26	0.77	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	6.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	164.62	51.37	2.13	4.39	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	77.36	28.59	3.55	4.43	3.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	278.21	73.75	1.79	8.07	6.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	83.68	37.77	2.93	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	122.26	40.16	3.84	8.56	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	120.16	30.75	2.70	4.41	1.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	145.43	65.07	3.90	3.42	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	98.64	27.40	6.39	3.65	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	60.36	15.66	1.01	1.52	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	48.97	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	88.21	23.84	3.34	0.48	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	66.66	24.78	3.69	1.33	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	43.48	13.99	3.87	1.29	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	52.06	20.05	3.99	1.68	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	195.67	78.42	2.32	4.49	2.63
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	255.46	78.69	9.70	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	142.85	49.61	2.99	2.99	2.39
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	134.85	62.82	5.12	3.41	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.26	12.56	2.04	2.20	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	123.59	50.52	6.94	2.72	4.23
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	109.45	35.73	6.14	2.96	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	112.31	43.47	5.43	3.62	9.66
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	95.37	42.12	3.18	6.62	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	90.02	31.56	3.86	2.80	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	75.76	28.30	5.38	4.51	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	76.35	24.10	4.06	5.33	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	121.98	44.18	3.17	4.22	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	85.52	23.26	3.75	3.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1214.68	23.26	1.29	94.33	9.05
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	74.88	25.11	0.00	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	169.14	45.94	9.09	6.56	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	209.03	54.84	7.21	4.39	9.09
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	85.25	38.64	4.72	2.06	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	75.23	32.32	0.58	6.50	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	43.91	17.28	2.34	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	213.00	57.28	1.58	3.89	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	169.29	47.42	5.61	8.16	4.08
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	140.84	38.17	2.63	2.82	2.63
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	58.97	15.65	1.68	2.79	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	83.12	21.11	1.76	4.52	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	9.05	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	241.24	53.58	3.43	4.89	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	144.06	45.52	8.84	1.77	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	61.44	25.45	3.22	4.39	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.22	8.16	4.08	0.78	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	247.00	110.54	35.70	1.59	12.96
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	58.40	25.29	15.25	1.86	7.44
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	228.18	89.12	17.25	1.80	9.70
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	216.90	101.64	11.92	1.99	5.39
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	92.17	47.66	11.82	0.79	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	129.52	40.63	21.59	1.52	6.35
Smooth muscle cells - airway, control, donor2	11967-126D5	69.48	18.37	3.59	0.40	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	108.68	38.46	12.96	0.42	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	78.84	31.63	5.04	1.38	2.29
Synoviocyte, donor1	11291-117A4	180.44	53.86	13.97	3.87	3.37
Synoviocyte, donor2	11368-117I9	128.40	26.99	7.88	7.88	2.01
Synoviocyte, donor3	11440-118H9	139.18	27.26	9.38	3.35	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	88.98	37.52	2.50	3.22	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	101.08	33.69	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	86.60	29.64	1.62	3.94	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	68.39	22.22	0.72	2.15	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	47.93	18.56	0.39	3.48	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	66.43	13.17	2.29	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	111.34	15.62	1.23	4.18	0.74
Urethra, donor2	10319-105A4	115.10	30.57	5.40	3.60	0.00
Urothelial Cells, donor1	11520-119H8	88.73	31.08	2.66	2.92	1.86
Urothelial Cells, donor2	11600-120H7	60.49	19.23	4.41	1.20	2.00
Urothelial Cells, donor3	11681-122H7	85.04	18.34	4.35	1.60	2.06
Urothelial cells, donor0	11216-116B1	133.29	22.07	3.34	4.46	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	23.13	0.89	1.78	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	4.29	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	0.68	0.00	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.18	3.10	1.03	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.59	1.74	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	3.12	1.04	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	27.53	2.75	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	2.74	0.91	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.39	15.42	0.99	1.36	0.37
Wilms' tumor cell line:HFWT	10597-108E3	29.92	18.48	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	59.49	19.55	0.56	1.12	0.56
achilles tendon, donor2	10292-104G4	74.40	10.33	6.20	10.33	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.91	11.98	3.06	2.29	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.93	6.04	0.46	0.93	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.60	5.22	1.07	1.54	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	25.03	19.32	2.45	2.18	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	19.68	11.81	1.12	0.84	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.82	5.71	0.00	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	11.43	5.99	0.00	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8.37	9.69	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.15	7.35	0.82	1.63	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.86	7.77	0.39	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.60	3.13	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.71	9.06	0.46	2.32	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.17	5.95	0.26	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	11.98	4.38	0.00	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.65	2.32	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.97	6.58	1.65	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.19	7.67	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	20.06	3.84	0.00	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.20	7.58	0.30	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.70	8.18	0.72	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.71	8.02	0.89	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.35	16.01	0.67	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	14.87	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.33	11.30	0.00	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	17.01	7.85	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	7.50	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.02	3.30	0.71	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	118.20	22.34	2.33	6.05	1.86
adipose, donor1	10184-103D4	83.27	29.91	5.86	4.10	2.93
adipose, donor2	10185-103D5	42.98	23.52	2.03	1.22	0.81
adipose, donor3	10186-103D6	55.55	22.60	2.18	1.36	0.27
adipose, donor4	10187-103D7	57.21	18.20	2.60	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	39.77	37.40	0.00	0.47	0.32
adrenal gland, adult, pool1	10081-102A9	72.75	18.19	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.95	5.20	0.53	0.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.59	26.80	2.50	0.71	1.07
amniotic membrane cells, donor1	12235-129G3	188.03	40.81	6.49	4.17	1.62
amniotic membrane cells, donor2	12236-129G4	115.29	14.54	3.38	3.72	1.69
amniotic membrane cells, donor3	12237-129G5	184.72	22.98	5.89	3.83	2.36
amygdala - adult, donor10196	10167-103B5	691.32	578.67	24.90	9.49	16.60
amygdala, adult, donor10252	10151-102I7	1052.77	400.87	23.32	37.31	17.84
amygdala, newborn, donor10223	10360-105E9	232.72	158.48	10.33	3.87	6.46
anaplastic carcinoma cell line:8305C	10428-106D5	25.59	2.42	0.38	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	44.12	12.80	0.66	2.21	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.08	14.03	0.00	1.00	0.00
aorta, adult, pool1	10052-101G7	210.65	27.26	7.06	8.83	2.94
appendix, adult	10189-103D9	82.28	22.12	0.39	2.72	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.63	3.10	0.00	0.69	0.00
artery, adult	10190-103E1	82.88	13.59	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	178.19	26.37	5.07	5.94	1.45
b cell line:RPMI1788	10427-106D4	39.85	12.49	1.19	0.89	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	387.87	73.52	23.86	13.04	7.49
bile duct carcinoma cell line:HuCCT1	10432-106D9	131.88	28.68	1.59	3.27	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	31.13	4.18	0.84	0.84	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	6.71	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	135.37	19.12	3.04	4.35	1.52
blood, adult, pool1	10053-101G8	22.15	2.21	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	226.08	98.48	1.71	11.13	0.00
bone marrow, adult	10192-103E3	62.76	11.47	5.40	1.35	1.35
brain, adult, donor1	10084-102B3	413.10	166.06	18.45	15.38	7.18
brain, adult, pool1	10012-101C3	441.65	181.07	15.59	12.14	6.68
brain, fetal, pool1	10085-102B4	531.61	120.21	5.34	8.01	8.01
breast carcinoma cell line:MCF7	10482-107A5	32.38	12.22	0.33	2.31	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	55.05	9.99	1.12	1.75	0.37
breast, adult, donor1	10080-102A8	196.98	12.00	5.05	6.31	6.31
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.16	10.80	1.78	0.64	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	36.18	12.06	0.00	3.09	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.29	7.14	1.61	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	36.80	8.47	1.94	3.15	0.48
carcinoid cell line:NCI-H1770	10703-109H1	49.84	16.93	1.41	1.88	0.94
carcinoid cell line:NCI-H727	10735-110B6	41.56	5.91	0.66	2.30	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	12.04	4.75	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	70.27	42.85	3.73	2.66	1.86
caudate nucleus - adult, donor10196	10177-103C6	516.94	163.49	9.21	9.21	5.76
caudate nucleus, adult, donor10252	10164-103B2	713.81	231.91	15.56	22.76	14.22
caudate nucleus, adult, donor10258	10379-105H1	329.34	113.86	11.46	3.82	9.17
caudate nucleus, newborn, donor10223	10354-105E3	276.87	123.79	15.02	4.76	7.69
cerebellum - adult, donor10196	10173-103C2	722.49	183.54	2.91	2.91	8.74
cerebellum, adult, donor10252	10166-103B4	588.65	80.92	11.32	15.16	9.39
cerebellum, adult, pool1	10083-102B2	293.55	56.23	11.04	8.97	5.17
cerebellum, newborn, donor10223	10357-105E6	309.70	75.56	15.78	4.15	3.32
cerebral meninges, adult	10188-103D8	486.88	372.16	7.56	6.05	15.38
cerebrospinal fluid, donor2	10294-104G6	133.75	40.93	6.58	1.46	2.92
cervical cancer cell line:D98-AH2	10552-107I3	19.84	5.03	0.29	1.15	0.14
cervical cancer cell line:ME-180	10553-107I4	32.15	7.95	0.99	1.49	0.33
cervix, adult, pool1	10013-101C4	95.44	18.48	2.73	3.57	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	192.15	45.98	10.03	5.71	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	502.91	112.34	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.74	7.21	0.99	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	36.22	9.61	0.37	0.37	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	30.12	11.86	0.00	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	117.96	19.94	8.83	3.70	0.57
chorionic membrane cells, donor2	12239-129G7	155.51	36.99	5.17	6.76	1.89
chorionic membrane cells, donor3	12240-129G8	113.74	18.13	14.84	1.65	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.30	23.63	1.34	4.42	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.33	5.28	0.63	0.84	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	18.49	7.96	0.51	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.74	7.74	0.48	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.84	9.77	0.81	1.43	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	17.96	7.66	0.59	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	17.46	6.78	0.26	1.56	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.94	27.89	4.57	0.91	1.60
clear cell carcinoma cell line:TEN	10636-108I6	64.89	19.09	2.95	2.43	1.39
colon carcinoma cell line:CACO-2	10513-107D9	49.60	13.91	1.10	0.92	0.18
colon carcinoma cell line:COLO-320	10420-106C6	34.21	13.30	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	80.92	5.95	1.19	2.38	3.57
colon, adult, pool1	10014-101C5	65.10	9.17	1.53	2.47	0.71
colon, fetal, donor1	10070-101I7	42.64	9.89	0.62	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	22.10	14.45	0.42	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	21.43	7.85	1.21	0.91	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	19.32	7.05	1.13	1.13	0.42
corpus callosum, adult, pool1	10042-101F6	1015.40	164.96	11.17	23.88	4.64
cruciate ligament, donor2	10295-104G7	115.09	19.45	2.43	7.29	0.81
diaphragm, fetal, donor1	10069-101I6	80.26	13.64	1.61	2.41	1.61
diencephalon, adult	10193-103E4	511.90	106.79	8.88	12.72	14.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.52	7.58	2.30	1.15	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	69.50	26.16	0.51	2.31	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	53.92	46.70	3.13	1.69	0.48
ductus deferens, adult	10196-103E7	67.28	9.47	2.99	1.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	5.76	2.88	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	49.29	15.45	3.68	2.21	2.94
dura mater, adult, donor1	10041-101F5	118.76	34.36	1.24	6.61	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	132.36	56.63	4.89	2.89	3.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.23	12.75	1.29	0.57	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	99.89	24.05	0.62	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	40.87	14.23	0.91	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	87.68	22.85	0.62	2.78	1.23
embryonic pancreas cell line:2C6	10603-108E9	118.21	15.76	0.00	5.25	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	81.45	34.86	2.35	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	73.22	20.12	3.08	1.99	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	84.27	29.11	4.99	2.09	4.99
epidermoid carcinoma cell line:A431	10426-106D3	59.25	13.45	0.44	1.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	100.53	23.98	1.87	2.86	0.33
epididymis, adult	10197-103E8	71.79	18.42	2.51	2.30	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.01	29.63	3.55	1.42	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.00	18.09	1.18	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.82	6.29	1.97	1.31	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	48.82	6.00	1.97	2.46	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	44.36	7.28	2.02	2.80	0.34
esophagus, adult, pool1	10015-101C6	131.34	16.14	2.97	4.25	2.55
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	117.85	74.77	1.25	1.38	0.88
eye - muscle inferior rectus, donor1	10272-104E2	103.83	16.90	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	105.21	16.83	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	104.18	11.91	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	110.06	27.52	2.29	9.17	1.15
eye - vitreous humor, donor1	10268-104D7	186.55	99.10	1.46	4.37	0.00
eye, fetal, donor1	10054-101G9	291.86	46.78	13.22	6.36	4.58
fibrosarcoma cell line:HT-1080	10758-110E2	53.47	18.46	1.03	2.18	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	62.92	25.40	2.85	0.95	0.47
frontal lobe, adult, pool1	10040-101F4	566.60	268.06	5.63	14.36	4.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	79.87	16.51	3.00	1.50	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	155.08	50.11	2.19	2.47	0.64
gall bladder, adult	10198-103E9	84.26	22.45	1.93	5.31	2.17
gamma delta positive T cells, donor1	11937-126A2	11.27	2.68	1.07	3.76	0.00
gamma delta positive T cells, donor2	11938-126A3	16.81	4.86	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	68.43	15.00	4.44	2.32	4.22
gastric adenocarcinoma cell line:MKN45	10612-108F9	25.14	5.22	1.16	0.58	0.19
gastric cancer cell line:AZ521	10549-107H9	21.81	18.04	0.33	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	22.88	8.24	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	84.30	14.85	2.74	2.06	2.74
giant cell carcinoma cell line:LU65	10487-107B1	31.44	9.18	1.15	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	57.66	34.15	1.26	1.40	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	47.14	10.72	1.25	2.49	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	164.45	68.82	4.96	4.64	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	184.54	68.25	3.37	7.16	1.40
glioblastoma cell line:T98G	10485-107A8	43.05	12.03	1.43	1.77	0.22
glioma cell line:GI-1	10413-106B8	86.69	17.57	1.17	1.17	0.88
globus pallidus - adult, donor10196	10175-103C4	765.36	128.29	5.10	10.93	7.29
globus pallidus, adult, donor10252	10161-103A8	1290.28	162.57	17.33	47.35	17.82
globus pallidus, adult, donor10258	10367-105F7	721.57	121.86	21.91	4.11	9.58
globus pallidus, newborn, donor10223	10364-105F4	327.74	83.67	12.79	7.99	5.86
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	17.13	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	124.16	32.32	3.52	2.88	1.92
hIPS +CCl2, biol_rep1	14383-156B9	42.70	22.50	0.92	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	40.24	24.69	1.37	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	37.36	20.61	0.64	0.64	1.29
hIPS, biol_rep1	14380-156B6	10.06	21.56	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	30.86	21.26	2.06	0.00	0.69
hIPS, biol_rep3	14382-156B8	276.97	137.93	5.52	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	12.93	8.05	0.86	0.57	0.00
heart - mitral valve, adult	10205-103F7	149.18	20.33	3.59	4.48	3.59
heart - pulmonic valve, adult	10206-103F8	183.03	30.33	0.78	6.80	1.31
heart - tricuspid valve, adult	10207-103F9	272.27	37.47	1.67	8.33	7.49
heart, adult, diseased post-infarction, donor1	10050-101G5	136.72	18.16	3.47	4.49	1.02
heart, adult, diseased, donor1	10051-101G6	235.91	31.51	13.20	5.54	5.11
heart, adult, pool1	10016-101C7	229.06	46.23	0.69	5.29	1.38
heart, fetal, pool1	10046-101G1	260.09	45.18	2.46	8.11	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	286.62	39.18	5.24	6.17	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	48.76	11.89	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	23.98	7.40	0.77	1.44	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.36	6.92	0.85	0.85	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.32	7.68	0.61	1.52	0.51
hepatoma cell line:Li-7	10484-107A7	71.40	7.79	2.34	2.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.04	10.55	0.50	1.21	0.00
hippocampus - adult, donor10196	10169-103B7	735.30	338.79	12.30	6.62	11.36
hippocampus, adult, donor10252	10153-102I9	864.77	215.33	24.08	32.66	16.94
hippocampus, adult, donor10258	10374-105G5	276.86	250.47	7.97	1.49	5.98
hippocampus, newborn, donor10223	10363-105F3	195.27	102.22	10.22	3.17	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.79	18.31	4.27	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.49	16.30	3.14	1.18	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.80	12.95	1.52	0.00	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	15.79	2.26	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.08	21.69	18.33	3.10	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.47	23.92	2.28	0.38	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	38.54	26.57	2.92	1.17	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	40.72	30.81	2.15	3.02	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	48.38	25.86	3.75	0.83	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.96	32.91	2.37	2.84	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	67.98	32.95	6.43	2.73	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	39.72	31.65	1.35	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.92	12.21	1.72	1.88	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	31.93	12.28	9.33	0.49	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	13.09	3.49	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	60.33	28.83	5.54	3.05	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.00	23.98	2.62	1.74	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	49.98	28.99	10.99	0.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.79	21.85	2.83	1.70	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	46.84	30.92	1.36	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.40	24.75	2.19	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	55.36	23.84	4.90	2.94	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	56.61	25.26	3.77	2.03	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.53	26.31	4.48	1.49	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	30.30	12.01	2.03	1.29	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	36.80	15.12	2.28	0.86	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	36.75	16.74	1.22	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.16	28.17	8.80	1.41	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.88	20.59	2.53	1.58	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.12	27.84	2.12	1.51	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.20	29.48	4.14	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	19.26	1.33	1.99	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.07	26.42	1.80	1.80	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	70.81	39.37	6.90	4.09	5.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.01	30.29	3.03	5.30	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	58.81	34.61	4.70	1.68	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.26	13.28	2.66	0.97	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	21.39	11.14	3.12	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	28.78	8.78	2.93	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	60.21	35.45	2.75	1.53	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	55.31	19.52	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.66	30.78	7.28	1.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	46.52	35.03	3.28	3.28	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.27	24.25	3.98	0.72	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.23	28.47	1.78	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	57.28	33.41	3.58	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	83.69	46.59	3.52	3.66	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.11	30.71	5.66	2.42	1.89
immature langerhans cells, donor1	11904-125F5	201.22	91.77	3.87	5.09	2.42
immature langerhans cells, donor2	11905-125F6	109.31	30.10	2.38	3.96	0.79
insula, adult, pool1	10039-101F3	787.07	420.36	7.67	15.99	4.64
keratoacanthoma cell line:HKA-1	10791-110H8	25.04	3.90	0.98	2.93	0.00
kidney, adult, pool1	10017-101C8	67.49	13.82	1.40	2.50	1.30
kidney, fetal, pool1	10045-101F9	71.30	18.46	0.85	2.41	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.57	26.27	1.28	1.99	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.93	1.52	0.55	1.11	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	122.03	18.90	1.65	1.10	0.18
left atrium, adult, donor1	10079-102A7	114.96	13.08	2.72	5.99	1.09
left ventricle, adult, donor1	10078-102A6	150.69	11.12	3.54	4.05	3.54
leiomyoblastoma cell line:G-402	10721-110A1	28.46	19.15	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	180.34	62.51	16.53	5.03	6.83
leiomyoma cell line:15242A	10570-108B3	215.22	89.67	15.22	3.80	11.41
leiomyoma cell line:15425	10571-108B4	159.77	70.42	25.50	3.16	9.47
leiomyosarcoma cell line:Hs 5.T	10722-110A2	241.28	88.89	12.70	19.05	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	101.42	30.32	4.18	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	37.90	12.16	1.42	1.06	0.24
liposarcoma cell line:KMLS-1	10782-110G8	88.57	37.65	2.97	1.87	1.25
liposarcoma cell line:SW 872	10726-110A6	59.58	8.89	0.85	1.95	0.24
liver, adult, pool1	10018-101C9	31.12	5.02	0.97	2.43	0.32
liver, fetal, pool1	10086-102B5	25.40	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	1003.13	181.99	12.69	18.96	6.71
locus coeruleus, adult, donor10252	10165-103B3	959.48	165.54	26.76	34.51	18.09
locus coeruleus, adult, donor10258	10375-105G6	584.03	168.44	70.25	11.85	19.19
locus coeruleus, newborn, donor10223	10362-105F2	291.07	88.75	19.77	4.63	12.62
lung adenocarcinoma cell line:A549	10499-107C4	34.74	13.84	0.69	1.11	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	53.77	8.96	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.96	12.26	0.53	1.32	0.40
lung, adult, pool1	10019-101D1	123.56	21.50	2.36	4.13	1.42
lung, fetal, donor1	10068-101I5	150.70	32.25	0.57	1.14	1.43
lung, right lower lobe, adult, donor1	10075-102A3	75.15	11.91	3.67	7.33	3.67
lymph node, adult, donor1	10077-102A5	54.91	8.52	2.37	0.95	2.84
lymphangiectasia cell line:DS-1	10727-110A7	139.62	26.52	2.41	3.73	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.54	13.89	1.66	2.41	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	81.55	18.69	1.70	1.70	0.85
mature adipocyte, donor1	12231-129F8	125.65	42.18	0.44	5.77	1.33
mature adipocyte, donor2	12232-129F9	231.39	48.77	2.28	8.51	1.87
mature adipocyte, donor3	12233-129G1	157.41	39.35	1.19	8.06	2.61
mature adipocyte, donor4	12234-129G2	85.28	21.06	0.79	4.21	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.99	22.63	0.48	1.19	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	404.96	204.17	15.79	5.64	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	613.88	179.68	12.32	22.62	8.28
medial frontal gyrus, adult, donor10258	10368-105F8	255.10	120.72	11.12	3.81	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	234.14	152.26	13.65	2.99	13.65
medial temporal gyrus - adult, donor10196	10183-103D3	509.80	272.53	215.49	13.33	32.23
medial temporal gyrus, adult, donor10252	10156-103A3	713.07	212.01	8.91	24.62	8.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	165.66	146.40	7.71	3.85	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	100.48	43.06	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	218.95	159.37	8.61	3.23	1.79
medulla oblongata - adult, donor10196	10174-103C3	754.76	143.42	12.98	10.38	7.14
medulla oblongata, adult, donor10252	10155-103A2	837.80	115.17	13.93	28.33	11.30
medulla oblongata, adult, pool1	10038-101F2	1021.08	211.90	7.26	20.41	3.67
medulla oblongata, newborn, donor10223	10361-105F1	335.38	94.09	16.66	5.55	2.78
medulloblastoma cell line:D283 Med	10838-111E1	23.69	8.19	0.66	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	49.28	18.46	0.37	1.96	0.12
melanoma cell line:COLO 679	10514-107E1	102.78	32.20	2.87	4.89	0.43
melanoma cell line:G-361	10465-106H6	72.75	26.87	6.24	1.90	1.09
meningioma cell line:HKBMM	10691-109F7	39.80	8.86	1.99	2.17	3.08
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	5.29	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	11.67	9.59	0.26	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	80.09	30.69	4.30	2.15	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	155.42	44.35	8.18	4.36	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	71.64	44.72	5.80	0.41	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	138.79	27.81	6.88	3.93	2.81
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	140.38	33.89	6.74	3.47	2.31
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	77.74	42.34	3.47	2.08	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	248.87	36.73	7.21	5.66	4.46
mesenchymal precursor cell - cardiac, donor2	11753-123G7	135.14	33.93	4.26	2.99	3.11
mesenchymal precursor cell - cardiac, donor3	11754-123G8	65.26	24.54	3.71	1.59	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	109.92	30.25	4.59	3.38	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	163.89	50.08	6.83	2.28	2.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	164.68	46.77	4.94	3.62	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	112.22	36.67	4.01	5.40	2.21
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	86.22	38.40	5.59	1.05	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	135.16	40.02	9.80	1.63	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	107.84	46.01	4.67	3.59	3.95
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	121.35	27.62	3.83	3.83	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	161.42	70.45	8.21	2.51	8.44
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	120.41	69.23	11.75	0.84	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	92.95	24.96	3.14	1.34	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	144.69	31.86	6.21	4.81	2.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	120.02	34.61	4.79	2.58	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	130.20	46.07	3.72	1.72	4.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	156.20	82.94	19.79	9.26	13.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	111.88	46.58	4.57	5.48	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	90.29	40.67	6.39	3.58	3.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	108.63	46.85	5.50	2.09	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	94.27	43.75	5.55	6.47	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	84.49	40.72	4.24	3.29	2.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	94.43	46.71	6.09	2.71	3.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	89.99	50.69	5.50	4.72	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	72.29	44.02	6.95	2.78	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	106.43	46.15	5.48	6.35	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	90.80	38.60	4.91	4.24	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	91.81	41.10	5.77	5.77	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	150.33	47.67	2.20	8.80	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	77.20	34.24	4.70	3.02	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	81.47	40.94	4.50	3.68	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	76.03	41.67	2.58	2.15	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	65.63	54.69	5.47	5.47	13.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	118.79	56.81	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	90.94	46.44	4.87	2.92	5.52
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	106.21	43.65	5.82	2.91	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	106.62	52.24	5.86	3.73	7.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	89.95	42.52	4.09	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	89.41	44.70	2.72	0.78	5.83
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	81.85	35.68	14.69	4.20	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	68.55	28.81	6.95	1.99	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	23.84	4.77	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	91.91	35.58	5.34	2.96	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	76.76	35.34	2.44	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	78.54	46.24	5.70	3.17	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	43.11	16.90	0.34	2.41	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	58.03	10.75	6.45	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	6.89	10.33	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	34.23	4.48	3.26	1.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	47.67	8.74	3.18	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.71	5.90	0.59	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.42	5.92	0.62	1.25	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	5.35	4.01	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	40.21	15.37	2.37	3.55	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	7.70	10.27	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	50.25	9.64	2.75	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	3.96	1.48	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	30.28	8.97	4.49	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	3.82	1.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	42.72	7.66	1.61	0.81	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	8.72	4.36	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	8.87	1.27	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	9.71	0.61	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	13.56	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	47.77	9.88	4.12	1.65	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	47.42	17.66	1.59	1.19	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	67.82	10.71	3.24	2.60	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	63.15	16.30	10.19	1.02	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	339.66	121.47	0.77	6.96	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	138.67	58.82	2.13	1.89	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	143.17	51.43	4.40	4.87	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	183.76	55.56	8.55	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	103.26	22.19	12.33	4.52	2.06
mesothelioma cell line:Mero-25	10850-111F4	146.39	49.02	5.45	2.95	2.95
mesothelioma cell line:Mero-41	10851-111F5	118.81	46.69	3.42	2.93	3.67
mesothelioma cell line:Mero-48a	10852-111F6	138.84	50.04	5.54	6.20	4.65
mesothelioma cell line:Mero-82	10853-111F7	134.56	39.42	4.99	2.63	3.15
mesothelioma cell line:Mero-83	10854-111F8	86.81	30.81	2.55	1.70	1.19
mesothelioma cell line:Mero-84	10855-111F9	110.71	35.64	4.04	1.77	4.04
mesothelioma cell line:Mero-95	10856-111G1	128.78	51.76	3.52	4.35	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	172.11	88.79	5.96	2.82	3.98
mesothelioma cell line:NCI-H226	10846-111E9	98.64	40.90	4.52	2.53	3.08
mesothelioma cell line:NCI-H2452	10848-111F2	60.98	32.29	2.90	1.71	1.71
mesothelioma cell line:NCI-H28	10845-111E8	45.29	22.90	1.53	3.56	1.02
mesothelioma cell line:No36	10857-111G2	88.73	39.47	3.59	2.28	1.96
mesothelioma cell line:ONE58	10858-111G3	101.07	24.66	3.25	3.52	4.06
migratory langerhans cells, donor1	11901-125F2	304.01	116.11	11.52	4.80	12.67
migratory langerhans cells, donor2	11902-125F3	297.60	117.84	5.37	4.03	5.25
migratory langerhans cells, donor3	11903-125F4	253.07	111.82	2.87	5.03	2.87
mixed mullerian tumor cell line:HTMMT	10689-109F5	136.79	19.59	28.73	3.26	5.88
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.58	7.21	1.91	0.64	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	122.55	21.88	1.84	2.76	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.75	4.57	1.52	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.43	8.13	1.11	2.03	0.74
myeloma cell line:PCM6	10474-106I6	28.46	3.36	1.19	1.38	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	240.96	58.85	1.52	8.12	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	121.41	29.62	5.69	8.24	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	37.55	6.24	0.89	0.33	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.92	5.07	1.03	0.37	0.37
nasal epithelial cells, donor2	12227-129F4	69.55	11.59	0.00	2.21	1.10
neuroblastoma cell line:CHP-134	10508-107D4	19.10	7.13	0.23	1.84	0.46
neuroblastoma cell line:NB-1	10539-107G8	77.08	29.75	0.94	4.30	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	47.03	9.70	0.84	1.90	0.21
neuroblastoma cell line:NH-12	10555-107I6	22.73	6.71	0.56	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	19.45	10.91	0.71	1.90	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.35	4.91	0.95	0.48	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	11.27	5.43	0.40	0.60	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.26	19.07	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	198.03	52.43	2.66	5.59	0.80
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	11.84	3.72	0.17	1.01	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	8.01	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	149.40	40.72	9.62	6.41	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	113.78	37.58	8.15	3.42	6.83
nucleus accumbens, adult, pool1	10037-101F1	624.21	265.09	4.97	12.09	2.44
occipital cortex - adult, donor10196	10172-103C1	352.33	133.92	6.18	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	746.05	114.32	11.81	27.10	9.93
occipital cortex, newborn, donor10223	10355-105E4	204.17	160.86	5.46	2.55	2.55
occipital lobe, adult, donor1	10076-102A4	463.40	177.64	4.99	18.63	29.91
occipital lobe, fetal, donor1	10073-102A1	387.48	101.70	12.01	9.87	15.45
occipital pole, adult, pool1	10036-101E9	461.38	176.13	3.47	10.49	2.60
olfactory region, adult	10195-103E6	566.47	276.64	13.18	15.48	15.09
optic nerve, donor1	10277-104E7	1010.53	170.09	10.01	18.01	28.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	74.95	9.45	0.80	0.91	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	27.48	17.31	0.41	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.71	6.60	2.20	1.52	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	52.90	18.25	1.04	2.19	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	175.50	41.16	6.17	3.53	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	113.05	56.99	0.93	5.61	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	48.56	16.33	1.06	1.48	0.00
ovary, adult, pool1	10020-101D2	88.05	20.18	1.66	3.06	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	131.44	39.23	3.67	2.20	1.28
pancreas, adult, donor1	10049-101G4	33.86	5.64	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	25.44	5.31	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	134.07	27.60	8.18	4.60	7.15
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	77.82	18.71	1.49	2.65	0.33
paracentral gyrus, adult, pool1	10035-101E8	502.09	202.63	5.86	11.81	3.02
parietal cortex, adult, donor10258	10373-105G4	210.66	129.92	5.87	1.47	5.14
parietal lobe - adult, donor10196	10171-103B9	467.42	177.75	9.40	6.58	9.40
parietal lobe, adult, donor10252	10157-103A4	536.44	152.21	14.25	16.25	8.27
parietal lobe, adult, pool1	10034-101E7	607.23	215.10	6.08	14.01	2.47
parietal lobe, fetal, donor1	10072-101I9	364.66	96.01	16.49	6.79	8.73
parietal lobe, newborn, donor10223	10356-105E5	230.67	172.72	7.85	3.36	4.11
parotid gland, adult	10199-103F1	56.12	6.17	1.23	0.62	1.85
penis, adult	10200-103F2	76.27	16.11	7.52	3.22	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	39.79	18.59	1.49	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	98.20	15.30	2.33	2.48	0.58
pineal gland - adult, donor10196	10179-103C8	371.54	86.43	2.58	4.52	4.52
pineal gland, adult, donor10252	10160-103A7	374.28	65.14	7.70	14.81	1.18
pineal gland, adult, donor10258	10377-105G8	226.37	65.22	5.02	4.39	5.64
pituitary gland - adult, donor10196	10180-103C9	70.83	26.31	6.07	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	139.68	29.71	1.56	4.17	0.52
pituitary gland, adult, donor10258	10378-105G9	34.05	7.66	0.85	4.26	0.85
placenta, adult, pool1	10021-101D3	101.16	28.27	2.47	4.41	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	53.90	24.90	1.99	2.38	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	91.83	14.32	2.33	5.60	0.93
pons, adult, pool1	10033-101E6	516.75	113.35	4.73	10.67	1.98
postcentral gyrus, adult, pool1	10032-101E5	501.00	191.70	7.24	11.86	2.53
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	4.18	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	31.32	15.88	2.48	1.60	0.44
prostate cancer cell line:PC-3	10439-106E7	69.52	21.78	1.63	2.90	0.18
prostate, adult, pool1	10022-101D4	110.46	19.86	0.73	3.36	0.27
putamen, adult, donor10196	10176-103C5	828.82	291.77	21.25	26.20	16.52
putamen, adult, donor10252	10152-102I8	284.31	158.82	7.84	17.65	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	119.12	55.73	2.19	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	316.75	109.93	6.77	4.59	3.38
putamen, newborn, donor10223	10365-105F5	162.68	52.48	14.24	3.00	9.00
rectal cancer cell line:TT1TKB	10469-106I1	45.09	8.73	0.00	1.45	0.00
rectum, fetal, donor1	10067-101I4	91.81	19.47	1.39	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	83.74	32.86	3.39	3.82	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	4.97	2.90	0.41	0.83
retina, adult, pool1	10030-101E3	242.53	47.71	3.58	7.75	1.69
retinoblastoma cell line:Y79	10475-106I7	23.64	12.21	0.52	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.24	4.30	0.25	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	92.80	48.09	2.53	1.97	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	158.39	33.35	2.27	3.03	0.76
salivary acinar cells, donor1	11771-123I7	35.61	6.47	1.46	0.49	0.00
salivary acinar cells, donor2	11772-123I8	44.47	11.43	1.79	1.10	2.07
salivary acinar cells, donor3	11773-123I9	188.02	12.58	0.66	2.65	0.00
salivary gland, adult, pool1	10093-102C3	64.06	4.58	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	80.94	30.44	2.78	1.26	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	83.11	28.80	2.23	2.35	0.59
seminal vesicle, adult	10201-103F3	56.61	15.34	1.59	3.70	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	174.18	37.65	8.26	4.13	6.32
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	65.42	19.88	2.01	2.01	3.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	69.24	42.15	5.02	2.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	41.24	15.18	1.48	0.94	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	35.70	8.84	0.99	1.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.93	3.74	0.39	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	73.06	15.61	0.00	2.13	1.42
skeletal muscle, adult, pool1	10023-101D5	73.64	13.55	0.72	3.12	0.48
skeletal muscle, fetal, donor1	10066-101I3	75.38	19.10	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	85.22	20.83	3.79	10.10	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	30.35	12.01	1.33	2.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	79.12	19.23	4.41	1.89	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	44.52	49.54	2.12	1.73	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	17.80	6.92	0.33	1.81	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	77.85	52.44	1.77	0.97	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	66.90	17.43	1.53	5.01	0.65
small intestine, adult, pool1	10024-101D6	43.48	6.09	1.07	1.91	0.60
small intestine, fetal, donor1	10064-101I1	42.26	6.88	2.46	1.23	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	30.26	8.21	2.05	1.54	2.05
smooth muscle, adult, pool1	10048-101G3	122.25	10.86	4.39	4.91	1.81
somatostatinoma cell line:QGP-1	10781-110G7	56.02	4.56	0.54	1.61	0.27
spinal cord - adult, donor10196	10181-103D1	1400.98	219.54	71.57	27.99	30.05
spinal cord, adult, donor10252	10159-103A6	1390.59	200.29	15.38	37.46	11.43
spinal cord, adult, donor10258	10369-105F9	455.89	156.35	35.28	0.69	16.60
spinal cord, fetal, donor1	10056-101H2	586.05	157.95	13.42	20.73	15.86
spinal cord, newborn, donor10223	10359-105E8	498.70	127.20	21.12	7.81	13.78
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	311.85	67.36	6.27	11.95	1.79
spleen, adult, pool1	10025-101D7	93.17	18.28	1.21	5.07	0.77
spleen, fetal, pool1	10044-101F8	97.25	22.25	1.03	4.61	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	95.23	36.54	1.66	2.48	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	96.27	15.76	2.66	1.71	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	61.50	15.03	3.15	1.40	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	233.78	25.80	1.95	1.95	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.29	2.81	0.23	0.45	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.72	6.78	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	390.92	99.42	7.62	4.23	2.96
stomach, fetal, donor1	10062-101H8	121.75	10.68	0.00	6.41	0.00
submaxillary gland, adult	10202-103F4	38.74	7.98	1.14	1.71	0.57
substantia nigra - adult, donor10196	10178-103C7	1465.40	379.92	271.37	0.00	108.55
substantia nigra, adult, donor10252	10158-103A5	887.32	108.21	23.47	29.08	14.75
substantia nigra, adult, donor10258	10371-105G2	314.49	126.73	10.35	1.55	5.17
substantia nigra, newborn, donor10223	10358-105E7	364.59	105.99	20.49	5.65	11.31
synovial sarcoma cell line:HS-SY-II	10441-106E9	33.24	29.12	1.83	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	613.82	342.90	11.27	14.67	4.49
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	561.27	148.15	10.68	7.83	21.37
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	369.21	134.50	5.71	5.27	14.07
tenocyte, donor1	11763-123H8	210.86	57.60	17.46	9.08	6.63
tenocyte, donor2	11765-123I1	176.64	31.66	11.83	6.10	3.82
tenocyte, donor3	11768-123I4	179.77	52.26	13.71	4.08	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	59.32	26.34	0.85	1.87	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	105.13	24.36	2.77	4.16	1.70
teratocarcinoma cell line:PA-1	10807-111A6	57.19	33.01	1.55	1.86	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	77.82	21.07	1.40	1.52	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	41.98	18.53	1.13	1.51	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	76.89	12.54	1.42	2.07	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	23.12	29.64	3.58	0.00	1.63
testis, adult, pool1	10026-101D8	118.86	40.69	4.08	3.54	1.50
testis, adult, pool2	10096-102C6	141.64	64.05	5.86	1.80	4.51
thalamus - adult, donor10196	10168-103B6	787.14	134.69	7.73	11.04	16.56
thalamus, adult, donor10252	10154-103A1	783.13	103.30	12.66	26.26	10.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	215.55	69.28	7.70	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	276.51	53.36	25.20	5.93	6.75
thalamus, newborn, donor10223	10366-105F6	175.47	84.00	9.78	3.45	5.18
throat, adult	10209-103G2	68.91	12.23	1.75	4.49	2.75
throat, fetal, donor1	10061-101H7	68.56	13.71	2.44	2.74	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	25.44	22.06	0.60	0.79	0.20
thymus, adult, pool1	10027-101D9	24.16	6.36	0.70	1.39	0.10
thymus, fetal, pool1	10043-101F7	40.73	7.48	0.10	1.77	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	108.63	22.87	4.39	2.66	2.39
thyroid carcinoma cell line:TCO-1	10783-110G9	154.78	33.11	2.65	5.17	1.12
thyroid, adult, pool1	10028-101E1	96.77	17.17	2.24	2.52	1.12
thyroid, fetal, donor1	10060-101H6	63.54	14.50	3.16	1.85	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	21.56	0.00	0.00	0.00
tongue, adult	10203-103F5	56.05	14.19	2.56	0.93	3.26
tongue, fetal, donor1	10059-101H5	84.73	14.58	4.34	3.94	2.36
tonsil, adult, pool1	10047-101G2	93.06	14.53	0.20	3.91	0.30
trachea, adult, pool1	10029-101E2	101.27	21.68	1.06	3.44	0.82
trachea, fetal, donor1	10058-101H4	73.86	19.23	1.15	3.85	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	134.98	49.24	4.61	2.48	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	63.32	19.45	1.42	2.84	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	97.62	42.78	3.76	0.94	1.41
tridermal teratoma cell line:HGRT	10694-109G1	279.67	55.17	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.65	3.89	0.08	1.19	0.08
umbilical cord, fetal, donor1	10057-101H3	131.45	18.78	8.35	6.26	2.09
uterus, adult, pool1	10100-102D1	123.88	27.30	2.22	2.39	0.68
uterus, fetal, donor1	10055-101H1	93.17	25.60	3.07	5.12	2.05
vagina, adult	10204-103F6	173.18	25.20	1.94	2.58	2.58
vein, adult	10191-103E2	94.26	17.32	0.88	3.07	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	89.46	26.44	2.40	2.14	0.53